283 related articles for article (PubMed ID: 9190032)
1. The management of hemolytic disease in the fetus and newborn.
Bowman J
Semin Perinatol; 1997 Feb; 21(1):39-44. PubMed ID: 9190032
[TBL] [Abstract][Full Text] [Related]
2. Management of pregnancies complicated by anti-E alloimmunization.
Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
[TBL] [Abstract][Full Text] [Related]
3. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
4. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management.
Slootweg YM; Lindenburg IT; Koelewijn JM; Van Kamp IL; Oepkes D; De Haas M
Am J Obstet Gynecol; 2018 Oct; 219(4):393.e1-393.e8. PubMed ID: 30063902
[TBL] [Abstract][Full Text] [Related]
5. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
6. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for the fetus with alloimmune hemolytic disease.
Bowman JM
Transfus Med Rev; 1990 Jul; 4(3):191-207. PubMed ID: 2134630
[No Abstract] [Full Text] [Related]
8. [Perinatal hemolytic disease caused by anti-c. A clinical case].
Donoso Siña E; Herrera Gonzalez B; González Bruzzone P; Cuellar Castañón A
Rev Chil Obstet Ginecol; 1983; 48(3):175-9. PubMed ID: 6442780
[No Abstract] [Full Text] [Related]
9. Management of isoimmunization in the presence of multiple maternal antibodies.
Spong CY; Porter AE; Queenan JT
Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
[TBL] [Abstract][Full Text] [Related]
10. Maternal CW alloimmunization.
Bowman JM; Pollock J
Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
[TBL] [Abstract][Full Text] [Related]
11. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
[TBL] [Abstract][Full Text] [Related]
12. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
Houston BL; Govia R; Abou-Setta AM; Reid GJ; Hadfield M; Menard C; Noyd J; Main S; Zarychanski R
Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn.
Gottvall T; Hildén JO; Selbing A
Acta Obstet Gynecol Scand; 1994 Apr; 73(4):300-6. PubMed ID: 8160535
[TBL] [Abstract][Full Text] [Related]
14. Current clinical management of anti-Kell alloimmunization in pregnancy.
Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
[TBL] [Abstract][Full Text] [Related]
15. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
[TBL] [Abstract][Full Text] [Related]
16. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
[TBL] [Abstract][Full Text] [Related]
17. Maternal immunity to red cell antigens and fetal transfusion.
Gibble JW; Ness PM
Clin Lab Med; 1992 Sep; 12(3):553-76. PubMed ID: 1521427
[TBL] [Abstract][Full Text] [Related]
18. [Fetomaternal alloimmunization: role of cordocentesis].
Donner C; Kadri R; Heymans O; Lambermont M; Gosselin F; Rodesch F
Rev Med Brux; 1992 Apr; 13(4):124-8. PubMed ID: 1594825
[TBL] [Abstract][Full Text] [Related]
19. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
20. [Spectrophotometric characteristics of the amniotic fluid in Rh isoimmunization following intrauterine fetal blood transfusions].
Matrova TS; Vasileva Iu
Akush Ginekol (Sofiia); 1989; 28(1):30-2. PubMed ID: 2500862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
